P.130 Bumetanide versus placebo for core symptoms of autism spectrum disorder at 91 days (BAMBI): a single-centre, double-blinded, patient-randomized, placebo-controlled, phase-2-trial

Authors :: Mandy G. Keijzer-Veen
Jan J. Sprengers
H. A. Bruining
Bob Oranje
D. Van Andel
Floortje E Scheepers
S. Annelien
Nicolaas P.A. Zuithoff
Marc R. Lilien
Source :: European Neuropsychopharmacology. 40:S80-S81
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Full Text Access

Tools